Trials / Completed
CompletedNCT00232869
A Study of the SMART Stent in the Treatment SFA Disease.
A Clinical Investigation of the SIROlimus Coated Cordis SMART™ Nitinol Selfexpandable Stent for the Treatment of Obstructive Superficial Femoral Artery Disease.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 93 (actual)
- Sponsor
- Cordis US Corp. · Industry
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to assess the safety and performance of the sirolimus coated Cordis SMART™ nitinol self expandable stent device and its delivery system in the treatment of obstructive superficial femoral artery (SFA) disease in reducing percent in-stent mean lumen diameter stenosis in de novo or restenotic native lesions as compared to the uncoated SMART™ stent.
Detailed description
This is a multi-center, prospective, randomized, double blind, two-arm feasibility study evaluating the safety and performance of the sirolimus coated Cordis SMART™ nitinol self-expanding stent and delivery system as compared to the uncoated SMART™ stent and delivery system. It is anticipated that a total of 90 patients will be entered into the study. Patients will be randomized on a 1:1 basis of coated to uncoated stents. Ninety (90) patients with de novo or restenotic native SFA lesions will be randomized to the Sirolimus Coated SMART™ nitinol self-expanding stent or to the uncoated (bare) SMART™ stent. Patients will be followed for 24 months post-procedure, with all patients having duplex ultrasound and clinical assessments at discharge, 1, 6, 9, 18 and 24 months, angiography at 6 six months and plain X-ray at 18 months. This study will be conducted at nine investigational sites. (Protocol was amended where 56 additional patients were recruited and followed for up to 5 years.)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | drug-eluting stent | Sirolimus Coated Cordis SMART™ nitinol selfexpandable stent |
| DEVICE | bare-metal stent | SMART™ bare-metal stent |
Timeline
- Start date
- 2001-02-01
- Primary completion
- 2003-06-01
- Completion
- 2009-05-01
- First posted
- 2005-10-05
- Last updated
- 2010-02-04
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00232869. Inclusion in this directory is not an endorsement.